The novel approach of the medication represents a exciting breakthrough in the management of the condition. Different to existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide372752.bloggin-ads.com/65179926/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment